Professeur Serge Leyvraz

Professor Serge Leyvraz, MD is senior consultant at the Charité Comprehensive Cancer in the Charité Universitätsmedizin-Berlin since 2013.

Prof. S. Leyvraz studied Medicine in Switzerland mainly at the University Hospital in Lausanne, and did his complete training in Hematology-Oncology at the Mount Sinai School of Medicine in New York in the department of Professor James Holland.

In 1988, he was appointed as Head of the Foundation du Centre Pluridisciplinaire d’Oncologie at the CHUV, first as Privat-Docent and since 2009 as full Professor at the Faculty of Biology and Medicine at the University of Lausanne.

From 1988 to 2013, he succeeded to develop the oncology department to make it a multidisciplinary service widely recognized in Switzerland and abroad. The focus of the department was to develop the best patient-oriented care, in parallel to the expansion of the clinical and translational research.

The research goals of Prof.S. Leyvraz were mainly centered on the treatment of sarcomas, melanomas, especially ocular melanomas, and genetically modified cellular immunotherapies.

He was for more than 10 years the chairperson of the sarcoma group at the SAKK and of the ocular melanoma subgroup at the EORTC. He has been member, among others, of the Scientific Committee of SAKK, of Swiss Cancer Ligue, and of l’Intergroupe Francophone du Myélome.

He has been Expert for German Federal Ministery of Education and Research, Scientific board funding initiative for rare disease research consortia.
Prof. S. Leyvraz is author or co-author of more than 350 publications in high-impact medical journals.

In 1999 he co-founded with Mr Olivier Daulte the research foundation: Fond’Action contre le Cancer.